This bibliography shows the most interesting papers selected from pmc PubMedCentral which were newly included in covid19_influenza_macrophage_X
It is available online and for download at http://www.kidney.de/write/PMCmedVIP_covid19_influenza_macrophage_X.html
Skewed: Nephrology, Rheumatology, Immunology, Cell Biology, Research Methods. on-topic and educational Clinical Medicine.
The full table of all monthly collections is: at house-of-papers.com
PMC searches were done at moremed.org

1. Innate immunity in aging: impact on macrophage function.

Aging Cell 2004; 3 (4): 161-7

2. Galectin-3 Enhances Avian H5N1 Influenza A Virus-Induced Pulmonary Inflammation by Promoting NLRP3 Inflammasome Activation.

Am J Pathol 2018; 188 (4): 1031-1042

PMC6436110 3. ASK Family Kinases Are Required for Optimal NLRP3 Inflammasome Priming.

Am J Pathol 2018; 188 (4): 1021-1030

PMC4215025 4. WFDC1 is a key modulator of inflammatory and wound repair responses.

Am J Pathol 2014; 184 (11): 2951-64

PMC3873492 5. Histopathological evaluation of the diversity of cells susceptible to H5N1 virulent avian influenza virus.

Am J Pathol 2014; 184 (1): 171-83

PMC2966778 6. Highly pathogenic avian influenza virus H7N7 isolated from a fatal human case causes respiratory disease in cats but does not spread systemically.

Am J Pathol 2010; 177 (5): 2185-90

PMC2731136 7. Spread of infection and lymphocyte depletion in mice depends on polymerase of influenza virus.

Am J Pathol 2009; 175 (3): 1178-86

PMC5792176 8. Oxygen-dependent changes in lung development do not affect epithelial infection with influenza A virus.

Am J Physiol Lung Cell Mol Physiol 2017; 313 (5): L940-L949

PMC4773845 9. MicroRNA-155 regulates host immune response to postviral bacterial pneumonia via IL-23/IL-17 pathway.

Am J Physiol Lung Cell Mol Physiol 2016; 310 (5): L465-75

PMC4451400 10. Influenza induces IL-8 and GM-CSF secretion by human alveolar epithelial cells through HGF/c-Met and TGF-alpha/EGFR signaling.

Am J Physiol Lung Cell Mol Physiol 2015; 308 (11): L1178-88

PMC4669338 11. Ecto-5'-nucleotidase CD73 modulates the innate immune response to influenza infection but is not required for development of influenza-induced acute lung injury.

Am J Physiol Lung Cell Mol Physiol 2015; 309 (11): L1313-22

12. Absence of SP-A modulates innate and adaptive defense responses to pulmonary influenza infection.

Am J Physiol Lung Cell Mol Physiol 2002; 282 (3): L563-72

PMC6397979 13. Myeloid TBK1 Signaling Contributes to the Immune Response to Influenza.

Am J Respir Cell Mol Biol 2019; 60 (3): 335-345

PMC4742936 14. Regulation of Retinoic Acid Receptor Beta by Interleukin-15 in the Lung during Cigarette Smoking and Influenza Virus Infection.

Am J Respir Cell Mol Biol 2015; 53 (6): 822-33

PMC4824936 15. Dysregulation of Antiviral Function of CD8(+) T Cells in the Chronic Obstructive Pulmonary Disease Lung. Role of the PD-1-PD-L1 Axis.

Am J Respir Crit Care Med 2016; 193 (6): 642-51

PMC6851454 16. Viral pneumonia and pulmonary alveolar proteinosis: the cause and the effect, case report.

AME Case Rep 2019; 3 (ä): 41

PMC3088253 17. Immunotherapy with a combination of intravenous immune globulin and p4 peptide rescues mice from postinfluenza pneumococcal pneumonia.

Antimicrob Agents Chemother 2011; 55 (5): 2276-81

18. Protective effects of quercetin during influenza virus-induced oxidative stress.

Asia Pac J Clin Nutr 2000; 9 (4): 314-7

PMC5082774 19. ATGs help MHC class II, but inhibit MHC class I antigen presentation.

Autophagy 2016; 12 (9): 1681-2

PMC4080993 20. Effects of flavonoid-induced oxidative stress on anti-H5N1 influenza a virus activity exerted by baicalein and biochanin A.

BMC Res Notes 2014; 7 (ä): 384

PMC2009440 21. Cellular immunity to myelin basic protein in man and in animal model systems as measured by the macrophage migration inhibition test.

Br J Cancer 1975; 31 (5): 528-34

PMC2149059 22. Macrophage electrophoretic mobility (MEM) test in cancer: a critical evaluation.

Br J Cancer Suppl 1973; 1 (ä): 208-14

PMC1633122 23. Letter: Effect of viruses on lymphocyte reactivity.

Br Med J 1974; 1 (5901): 245

24. Adoptive Transfer of Tumor-Specific Th2 Cells Eradicates Tumors by Triggering an In Situ Inflammatory Immune Response.

Cancer Res 2016; 76 (23): 6864-6876

25. Tumors Escape CD4+ T-cell-Mediated Immunosurveillance by Impairing the Ability of Infiltrating Macrophages to Indirectly Present Tumor Antigens.

Cancer Res 2015; 75 (16): 3268-78

PMC5786505 26. Initiation of Antiviral B Cell Immunity Relies on Innate Signals from Spatially Positioned NKT Cells.

Cell 2018; 172 (3): 517-533.e20

PMC2758559 27. Intracellular microbes and haemophagocytosis.

Cell Microbiol 2008; 10 (11): 2151-8

PMC7039342 28. A Requirement for Argonaute 4 in Mammalian Antiviral Defense.

Cell Rep 2020; 30 (6): 1690-1701.e4

29. Macroautophagy Proteins Control MHC Class I Levels on Dendritic Cells and Shape Anti-viral CD8(+) T Cell Responses.

Cell Rep 2016; 15 (5): 1076-1087

PMC5799819 30. H5N1 influenza virus-specific miRNA-like small RNA increases cytokine production and mouse mortality via targeting poly(rC)-binding protein 2.

Cell Res 2018; 28 (2): 157-171

PMC1905511 31. Fish oil feeding enhances lymphocyte proliferation but impairs virus-specific T lymphocyte cytotoxicity in mice following challenge with influenza virus.

Clin Exp Immunol 2000; 119 (2): 287-92

PMC1553327 32. Antigen presentation by naive macrophages, dendritic cells and B cells to primed T lymphocytes and their cytokine production following exposure to immunostimulating complexes.

Clin Exp Immunol 1995; 102 (1): 46-52

PMC2757571 33. Whole lymphoma B cells allow efficient cross-presentation of antigens by dendritic cells.

Cytotherapy 2008; 10 (6): 642-9

PMC2870528 34. Epidemic influenza and vitamin D.

Epidemiol Infect 2006; 134 (6): 1129-40

35. Proteome analysis reveals ubiquitin-conjugating enzymes to be a new family of interferon-alpha-regulated genes.

Eur J Biochem 2000; 267 (13): 4011-9

PMC3926668 36. CD11c(+) cells primed with unrelated antigens facilitate an accelerated immune response to influenza virus in mice.

Eur J Immunol 2014; 44 (2): 397-408

37. Tolerance induction to self antigens by peripheral dendritic cells.

Eur J Immunol 2002; 32 (9): 2588-97

38. Role of IgM antibodies versus B cells in influenza virus-specific immunity.

Eur J Immunol 2002; 32 (8): 2229-36

39. Mouse pre-immunocytes as non-proliferating multipotent precursors of macrophages, interferon-producing cells, CD8alpha(+) and CD8alpha(-) dendritic cells.

Eur J Immunol 2001; 31 (11): 3403-12

40. Secondary hemophagocytic lymphohistiocytosis in zoonoses. A systematic review.

Eur Rev Med Pharmacol Sci 2012; 16 (10): 1324-37

PMC6862669 41. Comparison of cytokine profiles induced by nonlethal and lethal doses of influenza A virus in mice.

Exp Ther Med 2019; 18 (6): 4397-4405

42. A Cre-loxP based system for studying horizontal gene transfer.

FEBS Lett 2007; 581 (16): 2943-6

PMC6985362 43. IL-6 During Influenza-Streptococcus pneumoniae Co-Infected Pneumonia-A Protector.

Front Immunol 2019; 10 (ä): 3102

PMC6797929 44. Tissue-Resident Macrophages Limit Pulmonary CD8 Resident Memory T Cell Establishment.

Front Immunol 2019; 10 (ä): 2332

PMC6546726 45. Peritoneal Cells Mediate Immune Responses and Cross-Protection Against Influenza A Virus.

Front Immunol 2019; 10 (ä): 1160

PMC6064871 46. Tumor Killing by CD4(+) T Cells Is Mediated via Induction of Inducible Nitric Oxide Synthase-Dependent Macrophage Cytotoxicity.

Front Immunol 2018; 9 (ä): 1684

PMC5826352 47. K63-Linked Polyubiquitination on TRAF6 Regulates LPS-Mediated MAPK Activation, Cytokine Production, and Bacterial Clearance in Toll-Like Receptor 7/8 Primed Murine Macrophages.

Front Immunol 2018; 9 (ä): 279

PMC5693858 48. Protective Effect of Panax notoginseng Root Water Extract against Influenza A Virus Infection by Enhancing Antiviral Interferon-Mediated Immune Responses and Natural Killer Cell Activity.

Front Immunol 2017; 8 (ä): 1542

PMC5626850 49. Glutathione Fine-Tunes the Innate Immune Response toward Antiviral Pathways in a Macrophage Cell Line Independently of Its Antioxidant Properties.

Front Immunol 2017; 8 (ä): 1239

PMC5614920 50. Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1 Positively Modulates Matrix Metalloproteinase-9 Production in Alveolar Macrophages upon Toll-Like Receptor 7 Signaling and Influenza Virus Infection.

Front Immunol 2017; 8 (ä): 1177

PMC3995058 51. How Do CD4(+) T Cells Detect and Eliminate Tumor Cells That Either Lack or Express MHC Class II Molecules?

Front Immunol 2014; 5 (ä): 174

PMC3835958 52. A Novel Method Linking Antigen Presentation by Human Monocyte-Derived Macrophages to CD8(+) T Cell Polyfunctionality.

Front Immunol 2013; 4 (ä): 389

PMC5541272 53. Eupatorium fortunei and Its Components Increase Antiviral Immune Responses against RNA Viruses.

Front Pharmacol 2017; 8 (ä): 511

PMC4978536 54. An ENU-induced splicing mutation reveals a role for Unc93b1 in early immune cell activation following influenza A H1N1 infection.

Genes Immun 2014; 15 (5): 320-32

55. IFNs activate toll-like receptor gene expression in viral infections.

Genes Immun 2001; 2 (6): 349-55

56. Direct identification and quantification of host and viral miRNAs after influenza infection using the next generation ultra-high throughput DNA sequencer.

Hong Kong Med J 2015; 21 Suppl 4 (ä): 8-11

57. Role of cyclooxygenase-2 in H5N1 viral pathogenesis and the potential use of its inhibitors.

Hong Kong Med J 2013; 19 Suppl 4 (ä): 29-35

58. The role of influenza virus gene constellation and viral morphology on cytokine induction, pathogenesis, and viral virulence.

Hong Kong Med J 2009; 15 (3 Suppl 4): 21-3

PMC4079819 59. Differential roles of lung dendritic cell subsets against respiratory virus infection.

Immune Netw 2014; 14 (3): 128-37

60. Local Modulation of Antigen-Presenting Cell Development after Resolution of Pneumonia Induces Long-Term Susceptibility to Secondary Infections.

Immunity 2017; 47 (1): 135-147.e5

61. Cigarette smoke silences innate lymphoid cell function and facilitates an exacerbated type I interleukin-33-dependent response to infection.

Immunity 2015; 42 (3): 566-79

PMC4169736 62. TLR5-mediated sensing of gut microbiota is necessary for antibody responses to seasonal influenza vaccination.

Immunity 2014; 41 (3): 478-492

PMC3166771 63. NLRX1 protein attenuates inflammatory responses to infection by interfering with the RIG-I-MAVS and TRAF6-NF-kappaB signaling pathways.

Immunity 2011; 34 (6): 854-65

PMC4651765 64. The role of B-1 cells in inflammation.

Immunol Res 2015; 63 (1-3): 153-66

PMC3809700 65. Anti-Gal: an abundant human natural antibody of multiple pathogeneses and clinical benefits.

Immunology 2013; 140 (1): 1-11

PMC2913223 66. Masking of a cathepsin G cleavage site in vivo contributes to the proteolytic resistance of major histocompatibility complex class II molecules.

Immunology 2010; 130 (3): 436-46

PMC1782947 67. The influence of macrophage inflammatory protein-1alpha on protective immunity mediated by antiviral cytotoxic T cells.

Immunology 2003; 109 (1): 68-75

PMC2327029 68. Vitamin E supplementation increases T helper 1 cytokine production in old mice infected with influenza virus.

Immunology 2000; 100 (4): 487-93

PMC1456575 69. Mucosal immunoadjuvant activity of liposomes: role of alveolar macrophages.

Immunology 1996; 89 (4): 488-93

PMC1385423 70. Some properties of dendritic macrophages from peripheral lymph.

Immunology 1989; 68 (2): 233-9

PMC1555113 71. The inductive requirements for the primary in vitro generation of delayed-type hypersensitivity response to influenza virus in mice.

Immunology 1981; 44 (1): 17-28

PMC5699014 72. Influenza B Virus Triggering Macrophage Activation Syndrome in an Infant.

Indian J Crit Care Med 2017; 21 (11): 802-803

PMC166016 73. Expression of cytokine and chemokine genes by human middle ear epithelial cells induced by influenza A virus and Streptococcus pneumoniae opacity variants.

Infect Immun 2003; 71 (8): 4289-96

PMC313364 74. Enhancement of immunoglobulin G responses in mice against hepatitis B virus surface antigen, influenza virus hemagglutinin vaccine, and tetanus toxoid by 6-O-acylated muramyl dipeptides.

Infect Immun 1989; 57 (6): 1839-44

PMC348010 75. Enhancement of natural resistance to influenza virus in lipopolysaccharide-responsive and -nonresponsive mice by Propionibacterium acnes.

Infect Immun 1983; 39 (2): 726-35

PMC347722 76. Humoral and cellular responses of mice to infection with a cold-adapted influenza A virus variant.

Infect Immun 1982; 38 (1): 218-25

PMC350910 77. Alterations of pulmonary defense mechanisms by protein depletion diet.

Infect Immun 1981; 34 (2): 610-22

PMC415080 78. Virus susceptibility of mouse hemopoietic cells in vitro: inhibition of granulocyte-macrophage precursor cells by Newcastle disease virus.

Infect Immun 1975; 11 (3): 424-8

PMC3121950 79. The role of myeloid receptors on murine plasmacytoid dendritic cells in induction of type I interferon.

Int Immunopharmacol 2011; 11 (7): 794-801

80. Influenza A virus lacking the effector and C terminal domains of NS1 protein induces cytokines associated with high pathogenicity in mice.

Acta Virol 2020; 64 (1): 78-87

81. Diet-induced obesity reduces the production of influenza vaccine-induced antibodies via impaired macrophage function.

Acta Virol 2016; 60 (3): 298-306

82. Nature of polypeptides synthesized in influenza a virus-infected nonpermissive cells of the immune system.

Acta Virol 1983; 27 (1): 12-20

83. Comparison of the anti-influenza activities of antibodies and immune system cells administered intranasally to syngeneic mice.

Acta Virol 1982; 26 (5): 353-61

84. Glycosylation as a target for recognition of influenza viruses by the innate immune system.

Adv Exp Med Biol 2007; 598 (ä): 279-92

85. Immunostimulating agents against influenza virus infection in senescent rats.

Allerg Immunol (Leipz) 1988; 34 (4): 239-47

86. Antibodies against influenza and stimulated macrophages in the lung lavage fluid of mice following oral immunization.

Allerg Immunol (Leipz) 1983; 29 (4): 215-22

87. Hypersensitivity pneumonitis.

Allergy Asthma Proc 2019; 40 (6): 425-428

88. Inhibitory Effect of TNF-alpha Produced by Macrophages Stimulated with Grifola frondosa Extract (ME) on the Growth of Influenza A/Aichi/2/68 Virus in MDCK Cells.

Am J Chin Med 2008; 36 (6): 1171-83

89. Macrophage-mediated inhibitory effect of Zingiber officinale Rosc, a traditional oriental herbal medicine, on the growth of influenza A/Aichi/2/68 virus.

Am J Chin Med 2006; 34 (1): 157-69

90. Evidence of Renal Infection in Fatal Cases of 2009 Pandemic Influenza A (H1N1).

Am J Clin Pathol 2011; 136 (3): 416-23

91. Lower respiratory tract delivery, airway clearance, and preclinical efficacy of inhaled GM-CSF in a postinfluenza pneumococcal pneumonia model.

Am J Physiol Lung Cell Mol Physiol 2020; 318 (4): L571-L579

92. Dynamics of IFN-beta Responses during Respiratory Viral Infection. Insights for Therapeutic Strategies.

Am J Respir Crit Care Med 2020; 201 (1): 83-94

93. Interleukin-10 gene expression in acute virus-induced asthma.

Am J Respir Crit Care Med 2005; 172 (4): 433-9

94. Expression of costimulatory molecules on alveolar macrophages in hypersensitivity pneumonitis.

Am J Respir Crit Care Med 1999; 159 (6): 1830-4

95. Mononuclear phagocytes of transport-stressed horses with viral respiratory tract infection.

Am J Vet Res 1985; 46 (11): 2272-7

96. Polymicrobial respiratory disease in pigs.

Anim Health Res Rev 2011; 12 (2): 133-48

97. Immune responses to influenza virus in rabbits after local immunization. II. Local and systemic cell mediated response.

Ann Microbiol (Paris) 1977; 128A (3): 349-64

98. Interaction between interferon and host genes in antiviral defense.

Ann N Y Acad Sci 1980; 350 (ä): 558-65

99. Khimiopreparaty v terapii grippa i drugikh respiratornykh virusnykh infektsii u detei.

Antibiot Khimioter 1998; 43 (9): 29-34

100. Antitumor, antiviral and immunopotentiating activities of pine cone extracts: potential medicinal efficacy of natural and synthetic lignin-related materials (review).

Anticancer Res 1991; 11 (2): 881-8

101. Effect of intramuscularly injected polyprenols on influenza virus infection in mice.

Antivir Chem Chemother 2000; 11 (3): 239-47

102. Efficacy of peroxisome proliferator activated receptor agonist in the treatment of virus-associated haemophagocytic syndrome in a rabbit model.

Antivir Ther 2010; 15 (1): 71-81

103. JNJ872 inhibits influenza A virus replication without altering cellular antiviral responses.

Antiviral Res 2016; 133 (ä): 23-31

104. Antiviral effect of a selective COX-2 inhibitor on H5N1 infection in vitro.

Antiviral Res 2011; 91 (3): 330-4

105. Effect of Hochu-ekki-to (TJ-41), a Japanese herbal medicine, on the survival of mice infected with influenza virus.

Antiviral Res 1999; 44 (2): 103-11

106. Formation of lymph follicles in draining lymph nodes after local injection of various antigenic substances in mice.

Arch Histol Jpn 1986; 49 (1): 25-37

107. Relapsing central and peripheral demyelinating diseases. Unusual pathologic features.

Arch Neurol 1986; 43 (6): 626-9

108. [Lung tissue factor expression changes in relation to the stage of respiratory distress syndrome in the presence of pneumonia in A/H1N1 influenza].

Arkh Patol 2013; 75 (6): 16-21

109. Activity of recombinant human alpha interferon against influenza virus infection in mice.

Biken J 1985; 28 (3-4): 79-82

110. Characterization and expression of the Mx1 gene in wild mouse species.

Biochem Genet 1998; 36 (9-10): 311-22

111. Amphipathic CRAC-Containing Peptides Derived from the Influenza Virus A M1 Protein Modulate Cholesterol-Dependent Activity of Cultured IC-21 Macrophages.

Biochemistry (Mosc) 2018; 83 (8): 982-991

112. Co-infection with Staphylococcus aureus after primary influenza virus infection leads to damage of the endothelium in a human alveolus-on-a-chip model.

Biofabrication 2020; 12 (2): 025012

113. Salivary agglutinin/glycoprotein-340/DMBT1: a single molecule with variable composition and with different functions in infection, inflammation and cancer.

Biol Chem 2007; 388 (12): 1275-89

114. Anti-viral activity of (-)- and (+)-usnic acids and their derivatives against influenza virus A(H1N1)2009.

Bioorg Med Chem Lett 2012; 22 (23): 7060-4

115. Identification of a leukemic counterpart of the plasmacytoid dendritic cells.

Blood 2001; 97 (10): 3210-7

PMC5905844 116. Critical regulation of inflammation via class A scavenger receptor.

Int J Chron Obstruct Pulmon Dis 2018; 13 (ä): 1145-1155

PMC2517549 117. Effect of Quercetin on lipid peroxidation and changes in lung morphology in experimental influenza virus infection.

Int J Exp Pathol 2003; 84 (3): 127-33

PMC5618544 118. Modulation of Immunogenicity and Conformation of HA1 Subunit of Influenza A Virus H1/N1 Hemagglutinin in Tubular Immunostimulating Complexes.

Int J Mol Sci 2017; 18 (9): ä

PMC5454946 119. An AAAG-Rich Oligodeoxynucleotide Rescues Mice from Bacterial Septic Peritonitis by Interfering Interferon Regulatory Factor 5.

Int J Mol Sci 2017; 18 (5): ä

PMC6052656 120. Arachidonic acid and other unsaturated fatty acids and some of their metabolites function as endogenous antimicrobial molecules: A review.

J Adv Res 2018; 11 (ä): 57-66

121. Protective mechanical ventilation does not exacerbate lung function impairment or lung inflammation following influenza A infection.

J Appl Physiol (1985) 2009; 107 (5): 1472-8

PMC4861475 122. Synchrotron Infrared and Deep UV Fluorescent Microspectroscopy Study of PB1-F2 beta-Aggregated Structures in Influenza A Virus-infected Cells.

J Biol Chem 2016; 291 (17): 9060-72

PMC3039347 123. Surfactant protein A (SP-A)-mediated clearance of Staphylococcus aureus involves binding of SP-A to the staphylococcal adhesin eap and the macrophage receptors SP-A receptor 210 and scavenger receptor class A.

J Biol Chem 2011; 286 (6): 4854-70

PMC2658045 124. Surfactant protein A modulates cell surface expression of CR3 on alveolar macrophages and enhances CR3-mediated phagocytosis.

J Biol Chem 2009; 284 (12): 7495-504

125. Critical role for Cryopyrin/Nalp3 in activation of caspase-1 in response to viral infection and double-stranded RNA.

J Biol Chem 2006; 281 (48): 36560-8

126. Influenza virus-induced AP-1-dependent gene expression requires activation of the JNK signaling pathway.

J Biol Chem 2001; 276 (24): 10990-8

127. Human MxB protein, an interferon-alpha-inducible GTPase, contains a nuclear targeting signal and is localized in the heterochromatin region beneath the nuclear envelope.

J Biol Chem 1996; 271 (38): 23478-86

PMC3114565 128. Chronic heat stress weakened the innate immunity and increased the virulence of highly pathogenic avian influenza virus H5N1 in mice.

J Biomed Biotechnol 2011; 2011 (ä): 367846

129. Bone-resorbing osteoclasts reveal a dynamic division of basal plasma membrane into two different domains.

J Cell Sci 1996; 109 ( Pt 2) (ä): 301-7

PMC6763218 130. Less burn, more fat: electronic cigarettes and pulmonary lipid homeostasis.

J Clin Invest 2019; 129 (10): 4077-4079

PMC6763255 131. Electronic cigarettes disrupt lung lipid homeostasis and innate immunity independent of nicotine.

J Clin Invest 2019; 129 (10): 4290-4304

PMC3461909 132. Alveolar epithelial cells orchestrate DC function in murine viral pneumonia.

J Clin Invest 2012; 122 (10): 3652-64

PMC3163966 133. Synergistic stimulation of type I interferons during influenza virus coinfection promotes Streptococcus pneumoniae colonization in mice.

J Clin Invest 2011; 121 (9): 3657-65

PMC1288832 134. Cross-reactive influenza virus-specific CD8+ T cells contribute to lymphoproliferation in Epstein-Barr virus-associated infectious mononucleosis.

J Clin Invest 2005; 115 (12): 3602-12

PMC267383 135. Absence of monocyte procoagulant activity during the immune response to influenza virus.

J Clin Microbiol 1989; 27 (4): 615-21

PMC502329 136. Histopathology of acute human immunodeficiency virus exanthema.

J Clin Pathol 1990; 43 (3): 201-2

PMC4612096 137. Critical role of phospholipase A2 group IID in age-related susceptibility to severe acute respiratory syndrome-CoV infection.

J Exp Med 2015; 212 (11): 1851-68

PMC2199114 138. Interferon (IFN) consensus sequence-binding protein, a transcription factor of the IFN regulatory factor family, regulates immune responses in vivo through control of interleukin 12 expression.

J Exp Med 1997; 186 (9): 1535-46

PMC2187379 139. Immune interferon induces the receptor for monomeric IgG1 on human monocytic and myeloid cells.

J Exp Med 1983; 158 (4): 1092-113

PMC2186399 140. Virus-specific interferon action. Protection of newborn Mx carriers against lethal infection with influenza virus.

J Exp Med 1981; 154 (1): 199-203

PMC2185613 141. Natural, genetically determined resistance toward influenza virus in hemopoietic mouse chimeras. Role of mononuclear phagocytes.

J Exp Med 1979; 150 (1): 117-26

PMC2184501 142. Inborn resistance of mice to myxoviruses: macrophages express phenotype in vitro.

J Exp Med 1978; 147 (2): 531-40

PMC2185098 143. Specific adsorption of H-2-restricted cytotoxi T cells to macrophage monolayers.

J Exp Med 1978; 148 (6): 1711-5

PMC5797944 144. Effects of PB1-F2 on the pathogenicity of H1N1 swine influenza virus in mice and pigs.

J Gen Virol 2017; 98 (1): 31-42

PMC4135086 145. Highly pathogenic avian influenza A H5N1 and pandemic H1N1 virus infections have different phenotypes in Toll-like receptor 3 knockout mice.

J Gen Virol 2014; 95 (Pt 9): 1870-1879

PMC6365009 146. Critical Adverse Impact of IL-6 in Acute Pneumovirus Infection.

J Immunol 2019; 202 (3): 871-882

PMC6008236 147. Effects of Influenza on Alveolar Macrophage Viability Are Dependent on Mouse Genetic Strain.

J Immunol 2018; 201 (1): 134-144

148. Involvement of NK Cells in IL-28B-Mediated Immunity against Influenza Virus Infection.

J Immunol 2017; 199 (3): 1012-1020

PMC5123812 149. IL-18 and Subcapsular Lymph Node Macrophages are Essential for Enhanced B Cell Responses with TLR4 Agonist Adjuvants.

J Immunol 2016; 197 (11): 4351-4359

PMC4185409 150. Innate receptors and cellular defense against pulmonary infections.

J Immunol 2014; 193 (8): 3842-50

151. DOK3 is required for IFN-beta production by enabling TRAF3/TBK1 complex formation and IRF3 activation.

J Immunol 2014; 193 (2): 840-8

152. Enhancer of zeste homolog 2 is a negative regulator of mitochondria-mediated innate immune responses.

J Immunol 2013; 191 (5): 2614-23

PMC3633673 153. Inflammatory response of mast cells during influenza A virus infection is mediated by active infection and RIG-I signaling.

J Immunol 2013; 190 (9): 4676-84

154. Uptake of particulate antigens in a nonmammalian lung: phenotypic and functional characterization of avian respiratory phagocytes using bacterial or viral antigens.

J Immunol 2012; 188 (9): 4516-26

PMC3477863 155. Complement-dependent transport of antigen into B cell follicles.

J Immunol 2010; 185 (5): 2659-64

PMC2924920 156. The migration of T cells in response to influenza virus is altered in neonatal mice.

J Immunol 2010; 185 (5): 2980-8

157. IL-10-dependent S100A8 gene induction in monocytes/macrophages by double-stranded RNA.

J Immunol 2009; 182 (4): 2258-68

158. Cytosolic antiviral RNA recognition pathway activates caspases 1 and 3.

J Immunol 2008; 180 (3): 1749-57

159. Insufficient perforin expression in CD8+ T cells in response to hemagglutinin from avian influenza (H5N1) virus.

J Immunol 2006; 176 (8): 4530-3

160. IFN-alpha regulates TLR-dependent gene expression of IFN-alpha, IFN-beta, IL-28, and IL-29.

J Immunol 2005; 174 (4): 1932-7

161. Autocrine type I IFN and contact with endothelium promote the presentation of influenza A virus by monocyte-derived APC.

J Immunol 2003; 170 (2): 1010-8

162. Effect of priming polymorphonuclear leukocytes with cytokines (granulocyte-macrophage colony-stimulating factor [GM-CSF] and G-CSF) on the host resistance to Streptococcus pneumoniae in chinchillas infected with influenza A virus.

Blood 1994; 83 (7): 1929-34

163. Anti-influenza virus effects of both live and non-live Lactobacillus acidophilus L-92 accompanied by the activation of innate immunity.

Br J Nutr 2013; 110 (10): 1810-8

164. Serum soluble CD163 levels in patients with influenza-associated encephalopathy.

Brain Dev 2013; 35 (7): 626-9

165. CD4(+) T cells indirectly kill tumor cells via induction of cytotoxic macrophages in mouse models.

Cancer Immunol Immunother 2019; 68 (11): 1865-1873

166. Differential mononuclear leukocyte attracting chemokine production after stimulation with active and inactivated influenza A virus.

Cell Immunol 1998; 186 (1): 1-7

167. A homogeneous population of lymphokine-activated killer (LAK) cells is incapable of killing virus-, bacteria-, or parasite-infected macrophages.

Cell Immunol 1990; 125 (1): 261-7

168. Macrophage procoagulant-inducing activity of influenza-specific effector T cells.

Cell Immunol 1984; 89 (2): 342-54

169. Protection of mice against influenza virus infection: enhancement of nonspecific cellular responses by Corynebacterium parvum.

Cell Immunol 1983; 78 (2): 314-25

170. Spontaneous cytotoxicity against viral-infected cells: effects of leucocytes and sera from older mice.

Cell Immunol 1982; 70 (1): 180-7

171. Influenza virus-induced interferon production in mouse spleen cell culture: T cells as the main producer.

Cell Immunol 1977; 32 (2): 243-51

172. Breach of IL-12 monopoly in the initiation of type 1 immunity to intracellular infections: IL-12 is not required.

Cell Mol Biol (Noisy-le-grand) 2001; 47 (4): 689-94

173. Mechanisms of Blood Brain Barrier Disruption by Different Types of Bacteria, and Bacterial-Host Interactions Facilitate the Bacterial Pathogen Invading the Brain.

Cell Mol Neurobiol 2018; 38 (7): 1349-1368

174. Synthesis of high-mannose oligosaccharide analogues through click chemistry: true functional mimics of their natural counterparts against lectins?

Chemistry 2015; 21 (5): 1978-91

175. Andrographolide as an anti-H1N1 drug and the mechanism related to retinoic acid-inducible gene-I-like receptors signaling pathway.

Chin J Integr Med 2014; 20 (7): 540-5

176. High prevalence of viral genomes and multiple viral infections in the myocardium of adults with "idiopathic" left ventricular dysfunction.

Circulation 2005; 111 (7): 887-93

177. Monocyte chemoattractant protein 1 contributes to an adequate immune response in influenza pneumonia.

Clin Immunol 2007; 125 (3): 328-36

178. Elevation of serum ferritin levels for predicting a poor outcome in hospitalized patients with influenza infection.

Clin Microbiol Infect 2020; ä (ä): ä

179. Kinetic profile of influenza virus infection in three rat strains.

Comp Med 2003; 53 (3): 293-8

180. Immunologic mechanism of Patchouli alcohol anti-H1N1 influenza virus may through regulation of the RLH signal pathway in vitro.

Curr Microbiol 2013; 67 (4): 431-6

181. How do viral infections predispose patients to bacterial infections?

Curr Opin Infect Dis 2004; 17 (3): 185-91

182. Cellular aspects of local antibody response in rabbits.

Dev Biol Stand 1975; 28 (ä): 145-51

183. Macrophages from disease resistant B2 haplotype chickens activate T lymphocytes more effectively than macrophages from disease susceptible B19 birds.

Dev Comp Immunol 2017; 67 (ä): 249-256

184. Porcine interferon-induced protein with tetratricopeptide repeats 3, poIFIT3, inhibits swine influenza virus replication and potentiates IFN-beta production.

Dev Comp Immunol 2015; 50 (1): 49-57

185. Antimicrobial responses of teleost phagocytes and innate immune evasion strategies of intracellular bacteria.

Dev Comp Immunol 2014; 43 (2): 223-42

186. Regulation of macrophage and dendritic cell function by pathogens and through immunomodulation in the avian mucosa.

Dev Comp Immunol 2013; 41 (3): 341-51

187. Cytologic features of vaping-induced lung injury: A case report.

Diagn Cytopathol 2020; 48 (2): 174-176

PMC6996567 188. Fetal monocytes possess increased metabolic capacity and replace primitive macrophages in tissue macrophage development.

EMBO J 2020; 39 (3): e103205

189. Influenza virus infection in mice after exposure to coal dust and diesel engine emissions.

Environ Res 1985; 37 (1): 44-60

190. The human intracellular Mx-homologous protein is specifically induced by type I interferons.

Eur J Immunol 1990; 20 (9): 2015-9

191. NB 06: From a simple lysosomotropic aSMase inhibitor to tools for elucidating the role of lysosomes in signaling apoptosis and LPS-induced inflammation.

Eur J Med Chem 2018; 153 (ä): 73-104

192. The burden of obesity on infectious disease.

Exp Biol Med (Maywood) 2010; 235 (12): 1412-24

193. WASP- mice exhibit defective immune responses to influenza A virus, Streptococcus pneumoniae, and Mycobacterium bovis BCG.

Exp Hematol 2005; 33 (4): 443-51

194. Use of cytokines in infection.

Expert Opin Emerg Drugs 2004; 9 (2): 223-36

195. Targeting eicosanoid pathways in the development of novel anti-influenza drugs.

Expert Rev Anti Infect Ther 2014; 12 (11): 1337-43

196. Effector mechanisms of influenza-specific antibodies: neutralization and beyond.

Expert Rev Vaccines 2018; 17 (9): 785-795

197. ELMOD2, a candidate gene for idiopathic pulmonary fibrosis, regulates antiviral responses.

FASEB J 2010; 24 (4): 1167-77

198. Influenza A virus replication is dependent on an antioxidant pathway that involves GSH and Bcl-2.

FASEB J 2003; 17 (6): 758-60

199. Human viral cardiomyopathy.

Front Biosci 2003; 8 (ä): s39-67

200. Live-attenuated auxotrophic mutant of Salmonella Typhimurium expressing immunogenic HA1 protein enhances immunity and protective efficacy against H1N1 influenza virus infection.

Future Microbiol 2017; 12 (ä): 739-752

201. H3N2 homeopathic influenza virus solution modifies cellular and biochemical aspects of MDCK and J774G8 cell lines.

Homeopathy 2013; 102 (1): 31-40

202. Oncolytic Activity of a Novel Influenza A Virus Carrying Granulocyte-Macrophage Colony-Stimulating Factor in Hepatocellular Carcinoma.

Hum Gene Ther 2019; 30 (3): 330-338

203. Fatal parvovirus myocarditis in a 5-year-old girl.

Hum Pathol 2001; 32 (3): 342-5

204. IL-24 is expressed by rat and human macrophages.

Immunobiology 2002; 205 (3): 321-34

205. Mapping the pulmonary environment of animals protected from virulent H1N1 influenza infection using the TLR-2 agonist Pam(2)Cys.

Immunol Cell Biol 2016; 94 (2): 169-76

206. Inhibition of lectin-mediated innate host defences in vivo modulates disease severity during influenza virus infection.

Immunol Cell Biol 2011; 89 (3): 482-91

207. Influenza viruses differ in ability to infect macrophages and to induce a local inflammatory response following intraperitoneal injection of mice.

Immunol Cell Biol 2010; 88 (6): 641-50

208. Effects of antigens on mononuclear leukocyte chemiluminescence.

Immunol Invest 1985; 14 (6): 503-14

209. Impact of the GK-1 adjuvant on peritoneal macrophages gene expression and phagocytosis.

Immunol Lett 2018; 201 (ä): 20-30

210. CD14 plays a limited role during influenza A virus infection in vivo.

Immunol Lett 2007; 113 (1): 47-51

211. Human influenza virus neuraminidase, but not hemagglutinin, induces murine macrophage interleukin 1 in vivo and in vitro.

Immunol Lett 1989; 22 (1): 41-6

212. Effector CD4+ and CD8+ T-cell mechanisms in the control of respiratory virus infections.

Immunol Rev 1997; 159 (ä): 105-17

213. Protective effect of adenylate deaminase (from Penicillium lanoso-viride) against acute infections in mice.

Immunopharmacology 1996; 35 (2): 163-9

214. Influenza a virus induced apoptosis: inhibition of DNA laddering & caspase-3 activity by zinc supplementation in cultured HeLa cells.

Indian J Med Res 2009; 129 (5): 579-86

215. FoxOs could play an important role during influenza A viruses infection via microarray analysis based on GEO database.

Infect Genet Evol 2019; 75 (ä): 104009

216. Inflammatory response and antigen localization following immunization with influenza virus ISCOMs.

Inflammation 1989; 13 (6): 641-9

217. Antiviral effects and mechanisms of Yinhuapinggan granule against H1N1 influenza virus infection in RAW264.7 cells.

Inflammopharmacology 2018; 26 (6): 1455-1467

218. Direct visualization of thymocyte apoptosis in neglect, acute and steady-state negative selection.

Int Immunol 1996; 8 (10): 1537-48

219. Lactobacillus fermentum CJL-112 protects mice against influenza virus infection by activating T-helper 1 and eliciting a protective immune response.

Int Immunopharmacol 2014; 18 (1): 50-4

220. Inhibition of H1N1 influenza A virus growth and induction of inflammatory mediators by the isoquinoline alkaloid berberine and extracts of goldenseal (Hydrastis canadensis).

Int Immunopharmacol 2011; 11 (11): 1706-14

221. Efficacy of oral administration of heat-killed probiotics from Mongolian dairy products against influenza infection in mice: alleviation of influenza infection by its immunomodulatory activity through intestinal immunity.

Int Immunopharmacol 2011; 11 (12): 1976-83

222. The bacterial extract OM-85 BV protects mice against influenza and Salmonella infection.

Int Immunopharmacol 2010; 10 (9): 1086-90

223. Oral administration of exopolysaccharide from Aphanothece halophytica (Chroococcales) significantly inhibits influenza virus (H1N1)-induced pneumonia in mice.

Int Immunopharmacol 2006; 6 (7): 1093-9

224. Primary immune system effects of the orally administered cyclopentane neuraminidase inhibitor RWJ-270201 in influenza virus-infected mice.

Int Immunopharmacol 2001; 1 (6): 1211-8

225. Characterization of monocyte differentiation-inducing (MDI) factors derived from human fetal membrane chorion cells undergoing apoptosis after influenza virus infection.

Int J Biochem Cell Biol 2006; 38 (11): 1926-38

226. Inhibition of influenza virus replication by cocaine.

Int J Immunopharmacol 2000; 22 (2): 105-11

227. Stimulation of microbicidal host defence mechanisms against aerosol influenza virus infection by lentinan.

Int J Immunopharmacol 1992; 14 (6): 971-7

228. Protection against influenza A virus infection in mice by oral immunization with a polyvalent bacterial lysate.

Int J Immunopharmacol 1991; 13 (7): 831-40

229. Immunostimulatory activity of 1-O-acylated muramyl dipeptides, with or without a 6-O-phosphoryl group, in aqueous form.

Int J Immunopharmacol 1989; 11 (1): 35-43

230. Effects of RU 41740 aerosol treatment on mouse bronchoalveolar cells, and protection afforded against influenza virus infection.

Int J Immunopharmacol 1987; 9 (7): 775-81

231. The immunomodulatory action of inosiplex in relation to its effects in experimental viral infections.

Int J Immunopharmacol 1983; 5 (3): 181-96

232. Influenza A virus-induced IFN-alpha/beta and IL-18 synergistically enhance IFN-gamma gene expression in human T cells.

J Immunol 1998; 160 (12): 6032-8

PMC5352889 233. The Expression of IL-6, TNF-alpha, and MCP-1 in Respiratory Viral Infection in Acute Exacerbations of Chronic Obstructive Pulmonary Disease.

J Immunol Res 2017; 2017 (ä): 8539294

PMC5144734 234. Increased Proinflammatory Responses of Monocytes and Plasmacytoid Dendritic Cells to Influenza A Virus Infection During Pregnancy.

J Infect Dis 2016; 214 (11): 1666-1671

PMC4564551 235. Interferon-Induced Transmembrane Protein-Mediated Inhibition of Host Cell Entry of Ebolaviruses.

J Infect Dis 2015; 212 Suppl 2 (ä): S210-8

PMC3733511 236. Heterozygosity for the F508del mutation in the cystic fibrosis transmembrane conductance regulator anion channel attenuates influenza severity.

J Infect Dis 2013; 208 (5): 780-9

PMC3164429 237. Lowering the threshold of lung innate immune cell activation alters susceptibility to secondary bacterial superinfection.

J Infect Dis 2011; 204 (7): 1086-94

PMC2941567 238. Mice lacking both TNF and IL-1 receptors exhibit reduced lung inflammation and delay in onset of death following infection with a highly virulent H5N1 virus.

J Infect Dis 2010; 202 (8): 1161-70

PMC3002343 239. Tetra-O-methyl nordihydroguaiaretic acid (Terameprocol) inhibits the NF-kappaB-dependent transcription of TNF-alpha and MCP-1/CCL2 genes by preventing RelA from binding its cognate sites on DNA.

J Inflamm (Lond) 2010; 7 (ä): 59

PMC6738789 240. Interferon-gamma inhibits nonopsonized phagocytosis of macrophages via an mTORC1-c/EBPbeta pathway.

J Innate Immun 2015; 7 (2): 165-76

PMC6741512 241. TLR7 contributes to the rapid progression but not to the overall fatal outcome of secondary pneumococcal disease following influenza A virus infection.

J Innate Immun 2013; 5 (1): 84-96

PMC2992405 242. Leucine-rich repeat (in Flightless I) interacting protein-1 regulates a rapid type I interferon response.

J Interferon Cytokine Res 2010; 30 (11): 843-52

PMC3040469 243. The anti-tumor agent, 5,6-dimethylxanthenone-4-acetic acid (DMXAA), induces IFN-beta-mediated antiviral activity in vitro and in vivo.

J Leukoc Biol 2011; 89 (3): 351-7

PMC3141719 244. Fulminant hemophagocytic lymphohistiocytosis induced by pandemic A (H1N1) influenza: a case report.

J Med Case Rep 2011; 5 (ä): 280

PMC3307392 245. Inflammatory effects of highly pathogenic H5N1 influenza virus infection in the CNS of mice.

J Neurosci 2012; 32 (5): 1545-59

246. Association of tumor necrosis factor-alpha with fever and pulmonary lesion score in pigs experimentally infected with swine influenza virus subtype H1N2.

J Vet Med Sci 2009; 71 (5): 611-6

PMC6430541 247. Epigenetic Modification Is Regulated by the Interaction of Influenza A Virus Nonstructural Protein 1 with the De Novo DNA Methyltransferase DNMT3B and Subsequent Transport to the Cytoplasm for K48-Linked Polyubiquitination.

J Virol 2019; 93 (7): ä

PMC5165214 248. CLEC5A-Mediated Enhancement of the Inflammatory Response in Myeloid Cells Contributes to Influenza Virus Pathogenicity In Vivo.

J Virol 2017; 91 (1): ä

PMC3416141 249. Mammalian innate resistance to highly pathogenic avian influenza H5N1 virus infection is mediated through reduced proinflammation and infectious virus release.

J Virol 2012; 86 (17): 9201-10

PMC3255855 250. Chicken cells sense influenza A virus infection through MDA5 and CARDIF signaling involving LGP2.

J Virol 2012; 86 (2): 705-17

PMC3209325 251. Major histocompatibility complex class II expression and hemagglutinin subtype influence the infectivity of type A influenza virus for respiratory dendritic cells.

J Virol 2011; 85 (22): 11955-63

PMC3126243 252. The NLRP3 inflammasome detects encephalomyocarditis virus and vesicular stomatitis virus infection.

J Virol 2011; 85 (9): 4167-72

PMC3028894 253. NP body domain and PB2 contribute to increased virulence of H5N1 highly pathogenic avian influenza viruses in chickens.

J Virol 2011; 85 (4): 1834-46

PMC3233149 254. Measles virus V protein inhibits NLRP3 inflammasome-mediated interleukin-1beta secretion.

J Virol 2011; 85 (24): 13019-26

PMC548444 255. Involvement of the Toll-like receptor 9 signaling pathway in the induction of innate immunity by baculovirus.

J Virol 2005; 79 (5): 2847-58

PMC1143636 256. Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis.

J Virol 2005; 79 (12): 7819-26

PMC109865 257. Comparisons of highly virulent H5N1 influenza A viruses isolated from humans and chickens from Hong Kong.

J Virol 1998; 72 (8): 6678-88

PMC188737 258. Expression of influenza virus hemagglutinin activates transcription factor NF-kappa B.

J Virol 1995; 69 (3): 1480-4

PMC250496 259. Antibody-mediated growth of influenza A NWS virus in macrophagelike cell line P388D1.

J Virol 1988; 62 (1): 20-6

PMC376009 260. Antiviral activity of chlorite-oxidized oxyamylose, a polyacetal carboxylic acid.

J Virol 1970; 5 (3): 321-8

PMC5770218 261. Cathepsin B plays a key role in optimal production of the influenza A virus.

J Virol Antivir Res 2018; 2018 (ä): 1-20

PMC5256138 262. Influenza A induces dysfunctional immunity and death in MeCP2-overexpressing mice.

JCI Insight 2017; 2 (2): e88257

PMC3875184 263. Inducible bronchus-associated lymphoid tissue (iBALT) synergizes with local lymph nodes during antiviral CD4+ T cell responses.

Lymphat Res Biol 2013; 11 (4): 196-202

PMC3128750 264. CD28 and IL-4: two heavyweights controlling the balance between immunity and inflammation.

Med Microbiol Immunol 2010; 199 (3): 239-46

PMC4295401 265. CD206+ cell number differentiates influenza A (H1N1)pdm09 from seasonal influenza A virus in fatal cases.

Mediators Inflamm 2014; 2014 (ä): 921054

266. Highly pathogenic H5N1 influenza virus causes coagulopathy in chickens.

Microbiol Immunol 2006; 50 (1): 73-81

267. Upregulated expression of Iba1 molecules in the central nervous system of mice in response to neurovirulent influenza A virus infection.

Microbiol Immunol 2000; 44 (8): 729-35

268. Mechanisms of augmented resistance of cyclosporin A-treated mice to influenza virus infection by trehalose-6,6'-dimycolate.

Microbiol Immunol 1992; 36 (10): 1061-75

269. Histologic and in situ viral findings in the myocardium in cases of sudden, unexpected death.

Mod Pathol 2002; 15 (9): 914-22

PMC4285429 270. Nedd8 regulates inflammasome-dependent caspase-1 activation.

Mol Cell Biol 2015; 35 (3): 582-97

PMC6821451 271. Recovery of TRIM25-Mediated RIG-I Ubiquitination through Suppression of NS1 by RNA Aptamers.

Mol Cells 2019; 42 (10): 721-728

PMC6259602 272. Antioxidant therapy as a potential approach to severe influenza-associated complications.

Molecules 2011; 16 (3): 2032-52

PMC5179326 273. Cytokine regulation of lung Th17 response to airway immunization using LPS adjuvant.

Mucosal Immunol 2017; 10 (2): 361-372

PMC5913291 274. Vibrio vulnificus quorum-sensing molecule cyclo(Phe-Pro) inhibits RIG-I-mediated antiviral innate immunity.

Nat Commun 2018; 9 (1): 1606

PMC5558830 275. Identification of a role for TRIM29 in the control of innate immunity in the respiratory tract.

Nat Immunol 2016; 17 (12): 1373-1380

PMC4406861 276. The receptor TREML4 amplifies TLR7-mediated signaling during antiviral responses and autoimmunity.

Nat Immunol 2015; 16 (5): 495-504

PMC4066330 277. GEF-H1 controls microtubule-dependent sensing of nucleic acids for antiviral host defenses.

Nat Immunol 2014; 15 (1): 63-71

PMC5994669 278. Modulation of mRNA Translation and Cell Viability by Influenza A Virus Derived Nonstructural Protein 1.

Nucleic Acid Ther 2018; 28 (3): 200-208

PMC5927530 279. Oncolytic influenza virus infection restores immunocompetence of lung tumor-associated alveolar macrophages.

Oncoimmunology 2018; 7 (5): e1423171

PMC5341866 280. Tumor-specific CD4+ T cells eradicate myeloma cells genetically deficient in MHC class II display.

Oncotarget 2016; 7 (41): 67175-67182

281. Neuraminidase inhibitors reduce nitric oxide production in influenza virus-infected and gamma interferon-activated RAW 264.7 macrophages.

Pharmacol Rep 2006; 58 (6): 924-30

PMC4275912 282. Nanoparticles modulate surfactant protein A and D mediated protection against influenza A infection in vitro.

Philos Trans R Soc Lond B Biol Sci 2015; 370 (1661): 20140049

PMC4569442 283. Cross Protection against Influenza A Virus by Yeast-Expressed Heterologous Tandem Repeat M2 Extracellular Proteins.

PLoS One 2015; 10 (9): e0137822

PMC4393251 284. Induction of microglia activation after infection with the non-neurotropic A/CA/04/2009 H1N1 influenza virus.

PLoS One 2015; 10 (4): e0124047

PMC4153650 285. The interferon-induced gene Ifi27l2a is active in lung macrophages and lymphocytes after influenza A infection but deletion of Ifi27l2a in mice does not increase susceptibility to infection.

PLoS One 2014; 9 (9): e106392

PMC4148262 286. Early activation of MAP kinases by influenza A virus X-31 in murine macrophage cell lines.

PLoS One 2014; 9 (8): e105385

PMC3790790 287. Lactobacillus plantarum DK119 as a probiotic confers protection against influenza virus by modulating innate immunity.

PLoS One 2013; 8 (10): e75368

PMC3538747 288. Inhibitory influence of Enterococcus faecium on the propagation of swine influenza A virus in vitro.

PLoS One 2013; 8 (1): e53043

PMC3503992 289. Influenza A(H1N1)pdm09 virus suppresses RIG-I initiated innate antiviral responses in the human lung.

PLoS One 2012; 7 (11): e49856

PMC3261190 290. Distinct regulation of host responses by ERK and JNK MAP kinases in swine macrophages infected with pandemic (H1N1) 2009 influenza virus.

PLoS One 2012; 7 (1): e30328

PMC3080395 291. Bordetella pertussis infection exacerbates influenza virus infection through pertussis toxin-mediated suppression of innate immunity.

PLoS One 2011; 6 (4): e19016

PMC3138787 292. Large scale comparison of innate responses to viral and bacterial pathogens in mouse and macaque.

PLoS One 2011; 6 (7): e22401

PMC3105060 293. Immunolocalization of influenza A virus and markers of inflammation in the human Parkinson's disease brain.

PLoS One 2011; 6 (5): e20495

294. Necrotizing epiglottitis and hemophagocytic lymphohistiocytosis.

Int J Pediatr Otorhinolaryngol 2009; 73 (1): 119-25

295. Prospects for HIV vaccines.

J Acquir Immune Defic Syndr (1988) 1988; 1 (3): 295-303

296. Impairment of phagosome-lysosome fusion in HIV-1-infected macrophages.

J Acquir Immune Defic Syndr Hum Retrovirol 1996; 13 (1): 18-22

297. Innate lymphoid cells and asthma.

J Allergy Clin Immunol 2014; 133 (4): 943-50; quiz 51

298. Expression of IL-6, IL-8, and RANTES on human bronchial epithelial cells, NCI-H292, induced by influenza virus A.

J Allergy Clin Immunol 1996; 98 (6 Pt 1): 1080-7

299. A pharmacologic study on the mechanism of action of Kakkon-to: body temperature elevation and phagocytic activation of macrophages in dogs.

J Altern Complement Med 2004; 10 (5): 841-9

300. Non-hydrolyzed in digestive tract and blood natural L-carnosine peptide ("bioactivated Jewish penicillin") as a panacea of tomorrow for various flu ailments: signaling activity attenuating nitric oxide (NO) production, cytostasis, and NO-dependent inhibition of influenza virus replication in macrophages in the human body infected with the virulent swine influenza A (H1N1) virus.

J Basic Clin Physiol Pharmacol 2013; 24 (1): 1-26

301. Therapeutic effect of Mahaenggamseok-tang on neutrophilic lung inflammation is associated with NF-kappaB suppression and Nrf2 activation.

J Ethnopharmacol 2016; 192 (ä): 486-495

302. Kegan Liyan oral liquid ameliorates lipopolysaccharide-induced acute lung injury through inhibition of TLR4-mediated NF-kappaB signaling pathway and MMP-9 expression.

J Ethnopharmacol 2016; 186 (ä): 91-102

303. Sudden death in toddlers caused by influenza B infection: a report of two cases and a review of the literature.

J Forensic Sci 2008; 53 (1): 213-5

304. Influenza A mutant viruses with altered NS1 protein function provoke caspase-1 activation in primary human macrophages, resulting in fast apoptosis and release of high levels of interleukins 1beta and 18.

J Gen Virol 2005; 86 (Pt 1): 185-195

305. The similar interaction of ferret alveolar macrophages with influenza virus strains of differing virulence at normal and pyrexial temperatures.

J Gen Virol 1983; 64 (Pt 8) (ä): 1807-10

306. Uncoupling of cytokine mRNA expression and protein secretion during the induction phase of T cell anergy.

J Immunol 1992; 148 (2): 381-7

307. Activation status of the CD4-8- gamma delta-T cells recovered from mice with influenza pneumonia.

J Immunol 1991; 147 (7): 2069-74

308. A virus-sensitive suppressor cell is involved in the regulation of human allospecific T cell-mediated cytotoxicity.

J Immunol 1989; 143 (7): 2209-15

309. Regulation of lymphokine response during reinfection by influenza virus. Production of a factor that inhibits lymphokine activity.

J Immunol 1989; 142 (10): 3560-7

310. Human T cell clones present antigen.

J Immunol 1989; 143 (2): 762-9

311. In vivo treatment of mice and hamsters with antibodies to asialo GM1 increases morbidity and mortality to pulmonary influenza infection.

J Immunol 1986; 136 (4): 1435-41

312. Macrophage dependency of in vitro B cell response to influenza virus antigens.

J Immunol 1980; 125 (6): 2679-84

313. Human macrophage and lymphocyte responses to mitogen stimulation after exposure to influenza virus, ascorbic acid, and hyperthermia.

J Immunol 1979; 123 (5): 1940-4

314. Induction of delayed hypersensitivity to influenza and mumps viruses in mice.

J Immunol 1969; 103 (4): 844-9

315. Developmental immunotoxicology (DIT): windows of vulnerability, immune dysfunction and safety assessment.

J Immunotoxicol 2008; 5 (4): 401-12

316. Matrix Metalloproteinase-13 in Atherosclerotic Plaque Is Increased by Influenza A Virus Infection.

J Infect Dis 2020; 221 (2): 256-266

317. Cytokine profiles induced by the novel swine-origin influenza A/H1N1 virus: implications for treatment strategies.

J Infect Dis 2010; 201 (3): 346-53